Provider

Noom Med

Item: Noom Med
Rating: 5.7
Author: halfrx

5.7

halfrx score

Behavior app first, prescription second. $249+ and it climbs with your dose.

All-in, per month

$199–$299

$249 once titrated — the figure this site scores on

✓ verified 2026-09-22Visit Noom Med ↗

Medication: compounded
Commitment: 3-month
Insurance: cash only
Price checked: 2026-09-22

Read from Noom's own pricing page on 11 September 2026. Three compounded tiers, each with an introductory first 4-week supply and a higher standing rate after it, all billed quarterly: Microdose $79 then $199 a month, GLP-1Rx $129 then $249, GLP-1Rx Plus $149 then $299. The page reads "$249/mo after the first 4-week supply (billed quarterly)" for GLP-1Rx and "$199/mo after the first 4-week supply (billed quarterly)" for Microdose. The monthly figure is not what leaves your account: each quarter is charged up front.

What this page used to say

2026-09-11 — A con quoting a price the card no longer holds. Was: $249+ for compounded semaglutide is $100/mo above Mochi and Found for the same molecule. Now: The $249 standing rate follows a $129 first supply, and every tier bills quarterly, so the monthly figure is not what leaves your account.
2026-09-11 — A point in its favor that no longer stood, withdrawn. Was: Month-to-month.
2026-09-11 — Noom's lowest tier went up. Was: $179 a month after a $49 first supply. Now: $199 a month after a $79 first supply.

Every correction on this site, dated →

How this monthly figure is built

One price covering medication.

What does Noom Med actually charge?

halfrx records Noom Med at $199–$299 a month all-in, read from its own published page on 2026-09-22. The figure that matters is $249 once titrated, because the starting dose is not the dose anyone stays on, and that is the number this site scores. It commits you for 3 months. No FTC action, state action, BBB F grade or FDA warning letter is recorded against it. It scores 5.7 out of 10 on a published formula that is arithmetic over the facts on this page, not an editor's opinion. The cheapest verified maintenance price on the site is $75, so this sits above the floor rather than at it. It is cash only: no insurance is billed, so the figure above is the whole of it. The medication is compounded rather than FDA approved: a copy made under the pharmacy-compounding exemption, which is a legal status and not a quality claim. Molecules: semaglutide, tirzepatide.

What it has cost

Up $20 a month since 2026-08-20

Last corrected on 2026-09-11 — see what this page used to say, above.

No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price

Compounding legal riskPrepay required

What is good about Noom Med?

+The behavior-change program is the actual product and it predates the drug business — relevant because weight regain after stopping a GLP-1 is the norm, not the exception.[1]

What are the downsides of Noom Med?

−The $249 standing rate follows a $129 first supply, and every tier bills quarterly, so the monthly figure is not what leaves your account.[1]
−Dose-scaled pricing — the quoted entry price is not your maintenance price.[1]
−Cash only, no prior-authorization support.[1]

How this score is built

2.0/2.5Cost — $249/mo at maintenance, scored against the $129–$699 spread of every verified price we track
0.0/2.5Medication — compounded medication, which the FDA does not review and which a court order can stop
1.0/1What they supply — strongest molecule offered: semaglutide, tirzepatide
0.5/1Commitment — three-month contract
1.0/1Care around the prescription — coaching, titration support and insurance help included
1.2/2Conduct — −0.8: compounding legal risk −0.8

The full formula →

Who compounds it

Names no compounding pharmacy anywhere this site could read. Read 2026-09-10 across /. Every seller audited the same way →

The public record

Lawsuits, regulator actions, FDA warning letters and BBB grade, each with the document behind it. Is Noom Med legit? →

Sources

[1] GLP-1 Telehealth Price Report 2026secondary
[2] Price read from www.noom.comprimary

Compare Noom Med with

Visit Noom Med ↗

Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.

The registers and documents behind this page

The public record on Noom Med is the result of searching these. They are named so the search can be repeated.

Warning letters, U.S. Food and Drug Administration — The register searched for every seller on this site. A letter found here is linked from the seller's page to the original.
Cases and proceedings, Federal Trade Commission — The register searched for advertising and billing actions against a seller.
Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.